Healthcare Equipment and Supplies
Company Overview of Auxogyn, Inc.
Auxogyn, Inc. provides novel scientific and clinically validated solutions to in vitro fertilization clinicians and their patients. The company offers Eeva system, a non-invasive device for the automated prognostic test of embryo development potential. It serves customers worldwide. The company was incorporated in 2008 and is based in Menlo Park, California.
1490 O’Brien Drive
Menlo Park, CA 94025
Founded in 2008
Key Executives for Auxogyn, Inc.
President and Chief Operating Officer
Group Senior Vice President of Commercial Development
Vice President of Medical and Scientific Affairs
Director of Biomedical Research
Compensation as of Fiscal Year 2014.
Auxogyn, Inc. Key Developments
Progyny Appoints Gary Hartonas as Senior Vice President, Commercial Development
Apr 30 15
Gary Harton, PhD has been appointed as new Group Senior Vice President, Commercial Development by Progyny. Dr. Harton would be playing the role for Progyny's commercial operations, comprising sales, marketing, and customer service operations throughout the products of Fertility Authority.com, EggBanxx, IVFAdvantage and The Eeva Test, the first and only FDA-cleared test to use time lapse imaging combined with their proprietary algorithm to aid in embryo selection during IVF. Prior to joining, Dr. Harton had a long career in the area of Reproductive Sciences, comprising both laboratory management and IVF practice management posts.
Auxogyn, Inc. Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-12-2014 09:10 AM
Jul 24 14
Auxogyn, Inc. Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-12-2014 09:10 AM. Venue: Le Parker Meridien, New York, New York, United States.
Auxogyn, Inc. Receives FDA Clearance for its Eeva(TM) System
Jun 10 14
Auxogyn, Inc. announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind. The Eeva System enables in vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test, which is the first prognostic, non-invasive test that provides objective information regarding embryo development to help optimize treatment plans for their patients.
Similar Private Companies By Industry
Recent Private Companies Transactions